Abstract
Introduction

Myeloid sarcoma (MS) is a solid tumor composed of immature myeloid cells (blasts); it may occurr as an isolated mass, or it may involve multiple organs. The condition was first described in 1811 by
, and in 1853, King real- ized that many of these tumors displayed a predominantly green colour, due to the presence of myeloperoxidase (MPO) in the tumorous tissue (2) . The term granulocytic sarcoma to describe MS was first suggested by Rappaport in 1966 (3) , then, in 2002, the World Health Organization adopted the use of the term myeloid sarcoma (4) . Cases have been reported of MS in the lymph nodes, skin, periosteum, genital system, central nervous system, heart, and gastrointestinal (GI) tract (5) (6) (7) (8) (9) . F i g u r e 2 . B o n e ma r r o w s me a r s ( MGG a n d P OX) a n d b i o p s y a n a l y s i s ( He ma t o x y l i n a n d E o s i n s t a i n i n g a n d CD3 4 ) c o n f i r me d AML .
Case Report
F i g u r e 3 . S i g n i f i c a n t t h i c k e n i n g a n d e d e ma o f t h e e n t i r e s ma l l -i n t e s t i n e wa l l wa s f o u n d . (Fig. 3) . The EGDS and colonoscopy were repeated, and they indicated that the stomach, duodenum, caecum, and colon had all been completely altered by a large number of polypoid infiltrative changes (Fig. 4) . Pathohistological analyisis confirmed the diagnosis of myeloid sarcoma, however, the patient refused treatment. (12) . In our opinion, the present patient had an isolated myeloid sarcoma that progressed quickly to AML. In fact, although an initial bone marrow analysis was not performed , the patient was admitted to the hospital without any significant abnormalities in blood count.
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Discussion
MS is likley underdiagnosed, and thus an accurrate prevalence rate for this disease is difficult to determine, however, it has been estimated that MS appears in 2/1,000,000 adults and 0.7/1,000,000 children (10). MS may occur as an isolated tumor without bone marrow infiltration (4), or, it may present as a disseminated disease involving many organs. Unless treated, almost 90% of patients who do not demonstrate any further haematological disorders will develop AML within 10.5-11 months (11). Involvement of the GI tract is relatively rare, being reported in 4 of 61 (7%) of tumors by Neiman et al
The prognosis of isolated myeloid sarcoma largely depends on how early it is first diagnosed. Gastrointestinal MS is difficult and complicated to diagnose, since it may present with a wide spectrum of non-specific simptoms, including jaundice, chronic diarrhea, nausea, anorexia, and abdominal pain. In the absence of hematological disorders, 46-75% of patients are initially diagnosed with conditions other than MS; most often, the misdiagnosis is NHL (13, 14) . During differential diagnosis, it is necessary to also consider poorly differentiated cancers and melanoma, and it children, neuroblastoma, rhabdomyosarcoma, Ewing sarcoma and medulloblastoma (15 (17) (18) (19) (20) (21) (22) (23) (24) .
Infiltration of the GI tract with leukemic cells is very rare and the prognosis for these patients is poor; they are at particular risk of complications such as perforation, bleeding, necrosis, obstruction, and intussusceptions (25) . If the tumor is localized, resection of the mass can be considered, but in the case of disseminated disease, treatment should be systemic.
